Cytoplasmic expression of Wilms tumor transcription factor-1 (WT1): a useful immunomarker for young-type fibromatoses and infantile fibrosarcoma.

[1]  R. Parenti,et al.  Wilms' tumor protein (WT1) in mammary myofibroblastoma: an immunohistochemical study. , 2014, Acta histochemica.

[2]  R. Parenti,et al.  Immunolocalization of Wilms' Tumor protein (WT1) in developing human peripheral sympathetic and gastroenteric nervous system. , 2014, Acta histochemica.

[3]  R. Parenti,et al.  Immunohistochemical expression of Wilms' tumor protein (WT1) in developing human epithelial and mesenchymal tissues. , 2013, Acta histochemica.

[4]  M. Miettinen,et al.  Immunoreactivity for Calretinin and Keratins in Desmoid Fibromatosis and Other Myofibroblastic Tumors: A Diagnostic Pitfall , 2012, The American journal of surgical pathology.

[5]  C. Loreto,et al.  Role of β-catenin expression in paediatric mesenchymal lesions: a tissue microarray-based immunohistochemical study , 2012, European journal of histochemistry : EJH.

[6]  R. Alaggio,et al.  Fibroblastic and Myofibroblastic Tumors in Children and Adolescents , 2012, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[7]  S. Hewitt,et al.  Wilms Tumor-1, Claudin-1 and Ezrin Are Useful Immunohistochemical Markers That Help to Distinguish Schwannoma from Fibroblastic Meningioma , 2012, Pathology & Oncology Research.

[8]  Inagaki Takuya,et al.  No Oncogenic Role for WT1 in Peripheral Nerve Sheath Tumors (Originals) , 2011 .

[9]  M. Fukuzawa,et al.  Expression of Wilms tumor 1 gene in a variety of pediatric tumors. , 2011, Journal of pediatric surgery.

[10]  A. Torrelo,et al.  Wilms Tumor 1 Expression in Vascular Neoplasms and Vascular Malformations , 2011, The American Journal of dermatopathology.

[11]  M. Fukuzawa,et al.  The role of WT1 gene in neuroblastoma. , 2011, Journal of pediatric surgery.

[12]  V. Huff,et al.  Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene , 2011, Nature Reviews Cancer.

[13]  T. Fukuda,et al.  No Oncogenic Role for WT1 in Peripheral Nerve Sheath Tumors , 2011 .

[14]  J. Powell,et al.  Differentiation of vascular tumors from vascular malformations by expression of Wilms tumor 1 gene: evaluation of 126 cases. , 2010, Journal of the American Academy of Dermatology.

[15]  C. Park,et al.  WT‐1 expression in gastrointestinal stromal tumours , 2010, Pathology.

[16]  R. Meyermann,et al.  WT1 expression in normal and neoplastic cranial and peripheral nerves is independent of grade of malignancy. , 2010, Cancer biomarkers : section A of Disease markers.

[17]  H. Asamura,et al.  Comparison of Different Clones (WT49 Versus 6F-H2) of WT-1 Antibodies for Immunohistochemical Diagnosis of Malignant Pleural Mesothelioma , 2009, Applied immunohistochemistry & molecular morphology : AIMM.

[18]  A. Lazar,et al.  Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. , 2008, The American journal of pathology.

[19]  D. Barisani,et al.  Morphologic Overlap between Infantile Myofibromatosis and Infantile Fibrosarcoma: A Pitfall in Diagnosis , 2008, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[20]  C. Fletcher,et al.  Immunohistochemistry for β‐catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature , 2007 .

[21]  Chengquan Zhao,et al.  Diagnostic Utility of WT1 Immunostaining in Ovarian Sertoli Cell Tumor , 2007, The American journal of surgical pathology.

[22]  Peter Hohenstein,et al.  The many facets of the Wilms' tumour gene, WT1. , 2006, Human molecular genetics.

[23]  I. Kawase,et al.  Immunohistochemical detection of WT1 protein in a variety of cancer cells , 2006, Modern Pathology.

[24]  J. Mulliken,et al.  Expression of Wilms tumor 1 gene distinguishes vascular malformations from proliferative endothelial lesions. , 2005, Archives of dermatology.

[25]  E. Raso,et al.  WT1 expression in angiogenic tumours of the skin , 2005, Histopathology.

[26]  H. Yoshikawa,et al.  Overexpression of the Wilms' tumor gene WT1 in human bone and soft‐tissue sarcomas , 2003, Cancer science.

[27]  J. Goldblum,et al.  Immunophenotype of Desmoplastic Small Round Cell Tumors as Detected in Cases with EWS-WT1 Gene Fusion Product , 2003, Modern Pathology.

[28]  K. Nichols,et al.  The Expression of WT1 in the Differentiation of Rhabdomyosarcoma from Other Pediatric Small Round Blue Cell Tumors , 2002, Modern Pathology.

[29]  D. Allred,et al.  Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomas. , 2009, Archives of pathology & laboratory medicine.

[30]  J. Goldblum,et al.  Enzinger and Weiss's Soft Tissue Tumors , 2001 .

[31]  T. Ishida,et al.  Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues. , 2001, American journal of clinical pathology.

[32]  P. Sorensen,et al.  Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors. , 2000, The American journal of surgical pathology.

[33]  I. Konishi,et al.  Immunohistochemical Detection of the Wilms' Tumor Gene (WT1) in Epithelial Ovarian Tumors , 2000, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[34]  T Ochi,et al.  Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. , 1998, Oncology research.

[35]  A. Charles,et al.  Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study. , 1997, Molecular pathology : MP.

[36]  E. van Marck,et al.  WT1 MUTATION IN MALIGNANT MESOTHELIOMA AND WT1 IMMUNOREACTIVITY IN RELATION TO p53 AND GROWTH FACTOR RECEPTOR EXPRESSION, CELL‐TYPE TRANSITION, AND PROGNOSIS , 1997, The Journal of pathology.

[37]  J. Barber,et al.  Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. , 1996, American journal of human genetics.

[38]  P. Ramani,et al.  THE EXPRESSION PATTERN OF WILMS' TUMOUR GENE (WT1) PRODUCT IN NORMAL TISSUES AND PAEDIATRIC RENAL TUMOURS , 1996, The Journal of pathology.

[39]  M. Tsuneyoshi,et al.  Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53. , 1994, The American journal of surgical pathology.

[40]  S. Mundlos,et al.  Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. , 1993, Development.

[41]  S. Sukumar,et al.  Molecular cloning of rat Wilms' tumor complementary DNA and a study of messenger RNA expression in the urogenital system and the brain. , 1992, Cancer research.

[42]  J. Bard,et al.  The candidate Wilms' tumour gene is involved in genitourinary development , 1990, Nature.

[43]  D. Housman,et al.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.